Amneal Pharmaceuticals

Senior Officer, QMS

Amneal Pharmaceuticals  •  State of Gujarāt, IN (Onsite)  •  9 hours ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

  • Prepare, review, and maintain Stability Summary Reports (SSRs) in accordance with approved stability protocols and regulatory requirements.
  • Compile and evaluate stability data received from QC and Stability teams to ensure accuracy and completeness of SSRs.
  • Manage document code creation, revision, issuance, and retirement as per the QA document control procedure.
  • Administer QA Documentation Cell activities, including issuance, control, retrieval, and archival of GMP documents.
  • Review SOPs, specifications, protocols, reports, and other quality documents for compliance with cGMP and Good Documentation Practices (GDP).
  • Ensure effective document lifecycle management through the Document Management System (DMS/eDMS).
  • Coordinate with QC, Production, Regulatory Affairs, R&D, and Stability teams for timely preparation and approval of SSRs and controlled documents.
  • Support internal audits, customer audits, and regulatory inspections by providing controlled documents and stability-related records.
  • Ensure compliance with data integrity (ALCOA+), document retention requirements, and applicable regulatory guidelines.
  • Drive continuous improvement and digitalization initiatives to enhance documentation and stability reporting processes.

Additional Responsibilities:

  • Stability Summary Report (SSR) Preparation and Stability Data Review.
  • Document Management System (DMS/eDMS) and Document Control.
  • Good Documentation Practices (GDP), cGMP, and Data Integrity (ALCOA+).
  • Regulatory Documentation, Audit Readiness, and Inspection Support.
  • Analytical Thinking, Cross-Functional Coordination, and Technical Documentation.

Education:

  • B. Pharm B. Pharm - Required
  • M. Pharm M. Pharm - Preferred

Experience:

  • 1 year or more in 1 - 4 Years

Specialized Knowledge: Licenses:

Amneal Pharmaceuticals

About Amneal Pharmaceuticals

Amneal (NASDAQ: AMRX) is rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affordable access to essential medicines. Our family delivers for yours through a robust U.S. generics business, a growing branded business and deepening portfolios in injectables, biosimilars and select international markets. We’ve bolstered our world-class scientific rigor, production capabilities and commercial infrastructure. And we invest substantially in our people through leadership development and employee well-being programs – all so we can deliver even more value. We are Amneal and We make healthy possible.

Content is for informational purposes only and 3rd party content does not reflect Amneal’s opinions.

Amneal has the right to remove comments that violate another’s copyright or intellectual property, mention an Amneal product, use profanity or are defamatory, promote and solicit for third-party sites, initiatives, or products, or are factually inaccurate or misleading or spam.

Amneal recommends that you consult with your healthcare provider regarding personal health matters. To report a product complaint or adverse event related to an Amneal product, contact Drug Safety at 877-835-5472, option 3 or drugsafety@amneal.com. If you are currently experiencing a life-threatening event, please immediately contact 911.

Industry
Chemicals & Materials
Company Size
5,001-10,000 employees
Headquarters
Bridgewater, New Jersey
Year Founded
2002
Social Media